Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AMYLO-CARTESIAN Study :Prevalence and Post-surgical Outcomes of CARdiac Wild-type TransthyrEtin amyloidoSIs in Elderly Patients With Aortic steNosis Referred for Valvular Replacement.

NCT02260466 is registered in ClinicalTrials.gov with French Cardiology Society as lead sponsor.

NCT NCT02260466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02260466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AMYLO-CARTESIAN Study :Prevalence and Post-surgical Outcomes of CARdiac Wild-type TransthyrEtin amyloidoSIs in Elderly Patients With Aortic steNosis Referred for Valvular Replacement.
Lead sponsor
French Cardiology Society
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2014
Completion date
April 25, 2025
Enrollment
186 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

aging, amyloidosis, aortic valve stenosis, heart disease